Hugo Fry
UK, Regional and Global positions at Servier | London, England, United Kingdom
Hugo Fry’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Chief Business Officer and Managing Director at 20Med Therapeutics in October 2023 - Present
Chief Executive Officer at Topas Therapeutics GmbH in April 2024 - Present
Chair of The Board at Zen Intelligence in October 2021 - December 2024
Chief Commercial Officer at Imbria Pharmaceuticals in December 2021 - August 2024
Chief Executive Officer at RQ Biotechnology Ltd. in January 2022 - September 2023
Life Science Leader | Pharmaceuticals and Biotech | Commercial, R&D, Industrial Affairs at Advisor | Board Member in July 2021 - June 2022
Managing Director – UK ► Commercial, Industrial, R&D | Innovative Healthcare Solutions at Sanofi in January 2017 - June 2021
Vice President ► Executive Leadership in Biosciences at The Association of the British Pharmaceutical Industry (ABPI) in May 2019 - April 2021
Board Member ► Executive Leadership in Biosciences at The Association of the British Pharmaceutical Industry (ABPI) in December 2016 - April 2021
Vice President, Chief Marketing Officer ► Commercial Strategy | Business Development at Sanofi Pasteur MSD in January 2015 - December 2016
Global Project Leader, Lixisenatide Family ► Cross-Functional Team Leadership | Pharmaceuticals at sanofi in January 2011 - December 2014
General Manager ► International Business | Revenue Growth | Integration Management at Zentiva in October 2010 - January 2011
Business Unit Director - Russia ► Commercial Operations | Oncology | Diabetes | Cardio-Hospital at sanofi-aventis in September 2008 - October 2010
Marketing Director - Russia ► Marketing Strategy | Portfolio Management at sanofi-aventis in January 2007 - September 2008
Marketing Support Director - Global Marketing ► Franchise Management at sanofi-aventis in January 2005 - December 2006
Head of Commercial Excellence ► Sales & Marketing Management at AVENTIS PHARMA LIMITED in September 2003 - December 2004
Brand Director | GM | Product, Sales & Training Manager ► Regional & Global Roles at Servier in January 1994 - January 2003
20Med Therapeutics is a biomedical company developing innovative solutions for efficient intracellular delivery of RNA and DNA based vacccines and therapeutics. 20Med's proprietary highly innovative nanoparticles are designed with several smart functions that make them efficient in protecting fragile payload, transport, cellular uptake, and release of active Oligonucleotide based payloads into the cytoplasm of target cells. 20Med's nanoparticles are flexible in functionalization and their unique properties make them applicable in a broad field of medical therapeutics.
Discover more about Servier
Director Strategy & Operations bij 20Med Therapeutics
Based on its proprietary bioresponsive polymer nanoparticle technology, we are building a non-viral delivery platform for the rapid development of mRNA vaccines Overall responsibilities: reporting directly to CEO and CBO, responsible for e.g.: investor relations, public and pr...
CEO at 20Med Therapeutics
Founding Board Member at Nanocell Therapeutics
(Feb 2019 – Present)
Senior Scientist Immunology
Senior Scientist Immunology at 20Med Therapeutics
(Aug 2021 – Present)
Member of the Supervisory Board at 20Med Therapeutics
Member of the Supervisory Board at 20Med Therapeutics
(Aug 2015 – Present)
Strategy & operations bij 20Med Therapeutics
Strategy & operations at 20Med Therapeutics
(Present)
What is Hugo Fry email address?
Email Hugo Fry at [email protected]. This email is the most updated Hugo Fry's email found in 2026.
How to contact Hugo Fry?
To contact Hugo Fry send an email to [email protected].
What company does Hugo Fry work for?
Hugo Fry works for Servier.
What is Hugo Fry's role at Servier?
Hugo Fry is UK, Regional and Global positions
What industry does Hugo Fry work in?
Hugo Fry works in the Pharmaceuticals industry.
